Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,646,180

« Back to Dashboard
Patent 5,646,180 protects AGENERASE and is included in two NDAs.

This patent has twenty-six patent family members in twenty-two countries.

Summary for Patent: 5,646,180

Title: Treatment of the CNS effects of HIV
Abstract:Methods and compositions for treating the central nervous system (CNS) effects of HIV, particularly AIDS related dementia.
Inventor(s): Chaturvedi; Pravin Ramsewak (Quincy, MA)
Assignee: Vertex Pharmaceuticals Incorporated (Cambridge, MA)
Application Number:08/567,199
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent PDF download available with subscription

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Glaxosmithkline
AGENERASE
amprenavir
CAPSULE;ORAL021007-001Apr 15, 1999DISCNNo5,646,180<disabled>TREATMENT OF HIV INFECTION
Glaxosmithkline
AGENERASE
amprenavir
CAPSULE;ORAL021007-002Apr 15, 1999DISCNNo5,646,180<disabled>TREATMENT OF HIV INFECTION
Glaxosmithkline
AGENERASE
amprenavir
SOLUTION;ORAL021039-001Apr 15, 1999DISCNNo5,646,180<disabled>TREATMENT OF HIV INFECTION
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 5,646,180

Country Document Number Publication Date Supplementary Protection Certificate SPC Country SPC Expiration
Portugal866696Mar 31, 2005
Ukraine61902Dec 15, 2003
Spain2231828May 16, 2005
Brazil9611861May 18, 1999
Australia722850Aug 10, 2000
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc